首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Significance of serum 25-hydroxyvitamin D3 and interleukin-6 levels in immunoglobulin treatment of Kawasaki disease in children
【2h】

Significance of serum 25-hydroxyvitamin D3 and interleukin-6 levels in immunoglobulin treatment of Kawasaki disease in children

机译:血清25-羟维生素D3和白介素6水平在免疫球蛋白治疗儿童川崎病中的意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the study was to investigate the significance of the level of serum 25-hydroxyvitamin D3 [25-(OH)D3] and interleukin (IL)-6 in serum prior to and after immunoglobulin treatment in children suffering from Kawasaki disease in order to provide a reference for the successful treatment of Kawasaki disease in children. From February, 2013 to February, 2015, 45 patients with Kawasaki disease were enrolled in the observation group. The normal control group comprised 43 healthy volunteers and the feverish control group 46 patients with respiratory infection and fever. Venous blood was collected from each case before and after immunoglobulin treatment and the level of 25-(OH)D3 and IL-6 in the serum were measured using fluorescent quantitative PCR, enzyme-linked immunosorbent assay and western blotting. Before treatment, the level of 25-(OH)D3 in the feverish control group was significantly lower than that of the normal control group, while the level of 25-(OH)D3 in the observation group was significantly higher than that of the normal control group. The level of 25-(OH)D3 in the feverish control group was lower than the IL-6 level in the normal children, but the difference was not statistically significant (P>0.05). The level 25-(OH)D3 in the observation group was significantly higher than the IL-6 level in the normal control group. The serum content of 25-(OH)D3 was significantly higher after the treatment compared to before treatment levels and after treatment IL-6 level was only slightly lower. It was observed that the 25-(OH)D3 level in the observation group was significantly increased after immunoglobulin treatment and this was positively correlated with the effects of the treatment. The IL-6 level had no significant changes after treatment and had little correlation with the treatment effect. The results suggested that 25-(OH)D3 may be involved in the occurrence of Kawasaki disease in children and in the aggravation of the disease to some extent.
机译:该研究的目的是为了研究川崎病患儿免疫球蛋白治疗前后血清25-羟维生素D3 [25-(OH)D3]和白介素(IL)-6的水平的意义。为成功治疗儿童川崎病提供参考。从2013年2月至2015年2月,观察组纳入了45例川崎病患者。正常对照组包括43名健康志愿者,发烧对照组包括46例呼吸道感染和发烧患者。在免疫球蛋白治疗之前和之后,从每个病例中收集静脉血,并使用荧光定量PCR,酶联免疫吸附测定和蛋白质印迹法测量血清中25-(OH)D3和IL-6的水平。治疗前,发烧对照组的25-(OH)D3水平明显低于正常对照组,而观察组的25-(OH)D3水平明显高于正常对照组。控制组。发热对照组的25-(OH)D3水平低于正常儿童的IL-6水平,但差异无统计学意义(P> 0.05)。观察组的25-(OH)D3水平明显高于正常对照组的IL-6水平。与治疗前相比,治疗后的25-(OH)D3血清含量明显更高,而治疗后IL-6水平仅略低。观察到观察组中免疫球蛋白治疗后25-(OH)D3水平显着升高,这与治疗效果呈正相关。治疗后IL-6水平无明显变化,与治疗效果无相关性。结果表明25-(OH)D3可能与儿童川崎病的发生有关,并在某种程度上加剧了该病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号